bluebird bio Secures up to $175 Million Debt Financing with Hercules Capital [Yahoo! Finance]
Hercules Capital, Inc. (HTGC)
Last hercules capital, inc. earnings: 2/20 04:10 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.htgc.com
Company Research
Source: Yahoo! Finance
First tranche of $75 million was drawn upon closing; the Company will be eligible to draw an additional $50 million subject to achievement of commercial milestones - SOMERVILLE, Mass., March 18, 2024 BUSINESS WIRE )--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio" or the "Company") today announced that it has entered into a $175 million five-year, term loan facility with Hercules Capital, Inc. (NYSE: HTGC) ("Hercules"). The transaction strengthens the Company's balance sheet as it executes on the commercial launches for its three FDA approved gene therapies – LYFGENIA for sickle cell disease, ZYNTEGLO for beta-thalassemia and SKYSONA for cerebral adrenoleukodystrophy. The term loan facility provides for up to $175 million of term loans in aggregate, available in four tranches. Upon closing of the transaction, the first tranche of $75 million was drawn. Under the terms of the agreement, bluebird will be eligible to draw two additional tranches of $25 million each, subject to the
Show less
Read more
Impact Snapshot
Event Time:
HTGC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HTGC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HTGC alerts
High impacting Hercules Capital, Inc. news events
Weekly update
A roundup of the hottest topics
HTGC
News
- Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the First Quarter 2024Business Wire
- SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumab [Yahoo! Finance]Yahoo! Finance
- SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumabPR Newswire
- SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumabPR Newswire
- Hercules Capital (HTGC) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates [Yahoo! Finance]Yahoo! Finance
HTGC
Earnings
- 2/15/24 - Beat
HTGC
Sec Filings
- 4/23/24 - Form DEF
- 4/15/24 - Form 4
- 4/15/24 - Form 4
- HTGC's page on the SEC website